Chemours Co (CC) : Apollo Management Holdings added new position in Chemours Co during the most recent quarter end. The investment management firm now holds 110,700 shares of Chemours Co which is valued at $1.1 Million , the company said in a statement filed on May 12, 2016 with the SEC.Chemours Co makes up approximately 0.04% of Apollo Management Holdings’s portfolio.
Other Hedge Funds, Including , Brave Asset Management Inc reduced its stake in CC by selling 1,000 shares or 17.69% in the most recent quarter. The Hedge Fund company now holds 4,654 shares of CC which is valued at $45,656. Chemours Co makes up approx 0.03% of Brave Asset Management Inc’s portfolio.Thompson Siegel Walmsley reduced its stake in CC by selling 700 shares or 90.91% in the most recent quarter. The Hedge Fund company now holds 70 shares of CC which is valued at $687. Diam Ltd. sold out all of its stake in CC during the most recent quarter. The investment firm sold 26,001 shares of CC which is valued $266,770. Parkside Financial Bank Trust added CC to its portfolio by purchasing 275 company shares during the most recent quarter which is valued at $2,822.Whitnell reduced its stake in CC by selling 180 shares or 18.65% in the most recent quarter. The Hedge Fund company now holds 785 shares of CC which is valued at $7,159.
Chemours Co closed down -0.28 points or -2.73% at $9.97 with 36,71,224 shares getting traded on Friday. Post opening the session at $10.29, the shares hit an intraday low of $9.5 and an intraday high of $10.5 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Chemours Co reported $0.06 EPS for the quarter, based on the information available during the earnings call on May 2, 2016. Analyst had a consensus estimate of $0.06. The company had revenue of $1297.00 million for the quarter, compared to analysts expectations of $1267.06 million. The company’s revenue was down -4.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.33 EPS.
Many Wall Street Analysts have commented on Chemours Co. Company shares were Reiterated by Barclays on May 9, 2016 to “Overweight”, Firm has raised the Price Target to $ 15 from a previous price target of $14 .Chemours Co was Upgraded by Goldman to ” Buy” on Mar 14, 2016. Chemours Co was Downgraded by Jefferies to ” Hold” on Feb 16, 2016.
The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.